Non-invasive evaluation of the GABAergic/glutamatergic system in autistic patients observed by MEGA-editing proton MR spectroscopy using a clinical 3 Tesla instrument

Journal of Autism and Developmental Disorders

Volumn 41, Issue 4, 2011, Pages 447-454

  Harada, Masafumi ^a   Taki, Masako M ^a   Nose, Ayumi ^a   Kubo, Hitoshi ^a   Mori, Kenji ^a   Nishitani, Hiromu ^a   Matsuda, Tsuyoshi ^b  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b GE HealthCare Japan   (Japan)

Author keywords

Autism; GABA; Glutamate; MEGA editing; MRS; NAA

Indexed keywords

4 AMINOBUTYRIC ACID; AMINO ACID; GLUTAMIC ACID; N ACETYLASPARTIC ACID; NEUROTRANSMITTER;

AMINO ACID SEQUENCE; ARTICLE; AUTISM; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FRONTAL LOBE; GABAERGIC SYSTEM; HUMAN; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SCHOOL CHILD;

ANALYSIS OF VARIANCE; ASPARTIC ACID; AUTISTIC DISORDER; CHILD; CHILD, PRESCHOOL; CORPUS STRIATUM; FRONTAL LOBE; GAMMA-AMINOBUTYRIC ACID; GLUTAMIC ACID; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY;

EID: 79956005283     PISSN: 01623257     EISSN: 15733432     Source Type: Journal    
DOI: 10.1007/s10803-010-1065-0     Document Type: Article

References (39)

1. Aasly, J., Silfvenius, H., Aas, T. C., Sonnewald, U., Olivecrona, M., Juul, R., et al. (1999). Proton magnetic resonance spectroscopy of brain biopsies from patients with intractable epilepsy. Epilepsy Research, 35, 211-217. (Pubitemid 29298114)
2. Aldred, S., Moore, K. M., Fitzgerald, M., & Waring, R. H. (2003). Plasma amino acid levels in children with autism and their families. Journal of Autism and Developmental Disorders, 33, 449-454.
3. Baslow, M. H. (2003). N-acetylaspartate in the vertebrate brain: Metabolism and function. Neurochemical Research, 28, 941-953.
4. Bauman, M., & Kemper, T. L. (1985). Histoanatomic observations of the brain in early infantile autism. Neurology, 35, 866-874. (Pubitemid 15025292)
5. Choi, C., Bhardwaj, P. P., Kalra, S., Casault, C. A., Yasmin, U. S., Allen, P. S., et al. (2007). Measurement of GABA and contaminants in gray and white matter in human brain in vivo. Magnetic Resonance in Medicine, 58, 27-33. (Pubitemid 47229914)
6. Choi, I.-Y., Lee, S.-P., Merkle, H., & Shen, J. (2006). In vivo detection of gray and white matter differences in GABA concentration in the human brain. NeuroImage, 33, 85-93.
7. Cook, E. H., Courchesne, R. Y., Cox, N. J., Lord, C., Gonen, D., Guter, S. J., et al. (1998). Linkage-disequilibrium mapping of autistic disorder, with 15q11-13 Markers. American Journal of Human Genetics, 62, 1077-1083. (Pubitemid 28199008)
8. Cote, C. J., & Wilson, S. (2006). Guidelines for monitoring and management of pediatric patients during and after sedation for diagnostic and therapeutic procedures: An update. Pediatrics, 118, 2587-2602. (Pubitemid 46397607)
9. Devito, T. J., Drost, D. J., Neufeld, R. W., Rajakumar, N., Pavlosky, W., Williamson, P., et al. (2007). Evidence for cortical dysfunction in autism: A proton magnetic resonance spectroscopic imaging study. Biological Psychiatry, 61, 465-473. (Pubitemid 46185338)
10. B receptors is altered in brains of subjects with autism. Cerebellum Nov 12 (Epub ahead of print).
11. Fatemi, S. H., Halt, A. R., Stary, J. M., Kanodia, R., Schulz, S. C., & Realmuto, G. R. (2002). Glutamic acid decarboxylase 65 and 67 kDa proteins are reduced in autistic parietal and cerebellar cortices. Biological Psychiatry, 52, 805-810.
12. A receptor downregulation in brains of subjects with autism. Journal of Autism and Developmental Disorders, 39, 223-230.
13. Friedman, S. D., Shaw, D. W. W., Artru, A. A., Dawson, G., Petropoulos, H., & Dager, S. R. (2006). Gray and white matter brain chemistry in young children with autism. Archives of General Psychiatry, 63, 786-794.
14. Friedman, S. D., Shaw, D. W., Artru, A. A., Richards, T. L., Gardner, J., Dawson, G., et al. (2003). Regional brain chemical alterations in young children with autism spectrum disorder. Neurology, 60, 100-107. (Pubitemid 36070652)
15. Guptill, J. T., Booker, A. B., Gibbs, T. T., Kemper, T. L., Bauman, M. L., & Blatt, G. J. (2007). [3H]-FLunitrazepam-labeled benzodiazepine binding sites in the hippocampal formation in autism: A multiple concentration autoradiographic study. Journal of Autism and Developmental Disorders, 37, 911-920. (Pubitemid 46790789)
16. Harada, M., Kubo, H., Nose, A., Nishitani, H., Matsuda, T. (in press) Measurement of variation in the human cerebral GABA level by in vivo MEGA-editing proton MR spectroscopy using a clinical 3 Tesla instrument and its dependence on brain region and the female menstrual cycle. Hum Brain Mapp.
17. Harada, M., Miyoshi, H., Uno, M., Okada, T., Hisaoka, S., Hori, A., et al. (1999). Neuronal impairment of adult moyamoya disease detected by quantified proton MRS and comparison with cerebral perfusion by SPECT with Tc-99m HM-PAO: A trial of clinical quantification of metabolites. Journal of Magnetic Resonance Imaging, 10, 124-129. (Pubitemid 29362425)
18. Hisaoka, S., Harada, M., Nishitani, H., & Mori, K. (2001). Regional magnetic resonance spectroscopy of the brain in autistic individuals. Neuroradiology, 43, 496-498. (Pubitemid 32591078)
19. Jensen, J. E., de Frederick, B., & Renshaw, P. F. (2005). Gray and white matter GABA level difference in the human brain using two-dimensional J-resolved spectroscopic imaging. NMR Biomed, 18, 570-576. (Pubitemid 43013898)
20. Lam, K. S. L., Aman, M. G., & Arnold, L. E. (2006). Neurochemical correlates of autistic disorder: A review of the literature. Research in Developmental Disabilities, 27, 254-289.
21. Levitt, J. G., O'Neill, J., McCracken, J. T., Guthrie, D., Toga, A. W., & Alger, J. R. (2003). Proton magnetic resonance spectroscopic imaging in childhood autism. Biological Psychiatry, 54, 1355-1366. (Pubitemid 37522159)
22. Lotspeich, L. J., & Ciaranello, R. D. (1993). The neurobiology and genetics of infantile autism. International Review of Neurobiology, 35, 87-129.
23. Ma, D. Q., Whitehead, P. L., Menold, M. M., etMartin, E. R., Ashley-Koch, A. E., Mei, H., et al. (2005). Identification of significant association and gene-gene interaction of GABA receptor subunit genes in autism. Am J Hum Genet, 77, 377-388.
24. Meshcer, M., Merkle, H., Kirsch, J., Garwood, M., & Gruetter, R. (1998). Simultaneous in vivo spectral editing and water suppression. NMR in Biomedicine, 11, 266-272. (Pubitemid 28465190)
25. Murphy, D. G., Critchley, H. D., Schmitz, N., MacAlonan, G., van Amelsvoort, T., Robertson, D., et al. (2002). Asperger syndrome: A proton magnetic resonance study of brain. Archives of General Psychiatry, 59, 885-891.
26. Novotny, E. J., Jr., Hyder, F., Shevell, M., & Rothman, D. L. (1999). GABA changes with vigabatrin in the developing human brain. Epilepsia., 40, 462-466. (Pubitemid 29164858)
27. Otsuka, H., Harada, M., Mori, K., Hisaoka, S., & Nishitani, H. (1999). Brain metabolites in the hippocampus-amygdala region and cerebellum in autism: An 1H-MR spectroscopy study. Neuroradiology, 41, 517-519. (Pubitemid 29348670)
28. Oz, G., Terpstra, M., Tkac, I., Aia, P., Lowary, J., Tuite, P. J., et al. (2006). Proton MRS of the unilateral substantia nigra in the human brain at 4 Tesla: Detection of high GABA concentrations. Magnetic Resonance in Medicine, 55, 296-301. (Pubitemid 43238097)
29. 1H-magnetic resonance spectroscopy study of amygdale-hippocampal and parietal regions in autism. American Journal of Psychiatry, 163, 2189-2192.
30. Petroff, O. A. C., Behar, K. L., Mattson, R. H., & Rothman, D. L. (1996). Human brain γ-aminobutyric acid levels and seizure control following initiation of vigabatrin therapy. Journal of Neurochemistry, 67, 2399-2404. (Pubitemid 26392510)
31. Petroff, O. A. C., Ogino, T., & Alger, J. R. (1988). High-resolution proton magnetic resonance spectroscopy of rabbit brain: Regional metabolite levels and postmortem changes. Journal of Neurochemistry, 51, 163-171.
32. Petroff, O. A. C., Rothman, D. L., Behar, K. L., & Mattson, R. H. (1995). Initial observations on effect of vigabatrin on in vivo 1H spectroscopic measurements of γ-aminobutyric acid, glutamate, and glutamine in human brain. Epilepsia, 36, 457-464.
33. Pouwels, P. J. W., Brockmann, K., Kruse, B., Wilken, B., Wick, M., Hanefeld, F., et al. (1999). Regional age dependence of human brain metabolites from infancy to adulthood as detected by quantitative localized proton MRS. Pediatric Research, 46, 474-485. (Pubitemid 29451836)
34. Provencher, S. E. (1993). Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magnetic Resonance in Medicine, 30, 672-679.
35. Samaco, R. C., Hogart, A., & Lasalle, J. M. (2004). Epigenetic overlap in autism-spectrum neurodevelopmental disorders: MECP2 deficiency causes reduced expression of UBE3A and GABRB3. Human Molecular Genetics, 14, 483-492. (Pubitemid 40277464)
36. Shinohe, A., Hashimoto, K., Nakamura Tsujii, M., Iwata, Y., Tsuchiya, K. J., Sekine, Y., et al. (2006). Increase serum levels of glutamate in adult patients with autism. Progress in Neuro- Psychopharmacology and Biological Psychiatry, 30, 1472-1477. (Pubitemid 44634960)
37. Terpstra, M., Henry, P.-G., & Gruetter, R. (2003). Measurement of reduced glutathione (GSH) in human brain using LCModel analysis of difference-edited spectra. Magnetic Resonance in Medicine, 50, 19-23. (Pubitemid 36841855)
38. Terpstra, M., Ugurbil, K., & Gruetter, R. (2002). Direct in vivo measurement of human cerebral GABA concentration using MEGA-editing at 7 Tesla. Magnetic Resonance in Medicine, 47, 1009-1012.
39. Weber, O. M., Verhagen, A., Duc, C. O., Meier, D., Leenders, K. L., & Boesiger, P. (1999). Effects of vigabatrin intake on brain GABA activity as monitored by spectrally edited magnetic resonance spectroscopy and positron emission tomography. Magnetic Resonance Imaging, 17, 417-425. (Pubitemid 29180204)